InsidersTradesSigma
申报总数
公司
▲ 买入（4 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
4
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+10.7%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the detailed record of transactions filed by Hsiao Jane Ph d, 首席技术官. Director active across 2 companies, notably Asensus Surgical, INC.. In total, 6 filings have been recorded. Split: 4 buys · 0 sell. Total volume traded: €291k. Activity tracked since 1 July 2021. The latest transaction was filed on 24 July 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Hsiao Jane Ph d
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
500,000 股0Common StockSEC:0000950170-24-087039:0
150,000 股@ US$0.9545.0% 占其流量Common StockSEC:0000950170-24-005070:0
标准退出：2024年4月16日 (T+90)
150,010 股@ US$0.872641.1% 占其流量Common StockSEC:0000950170-24-002743:0
标准退出：2024年4月4日 (T+90)
34,058 股@ US$1.2613.8% 占其流量Common StockSEC:0001209191-23-054918:0
标准退出：2024年2月8日 (T+90)
10 股@ US$3.730.0% 占其流量Common StockSEC:0001209191-21-050591:0
标准退出：2021年11月7日 (T+90)
29,231 股0Common StockSEC:0001209191-21-045178:0
6 条申报中的 6 条
About Hsiao Jane Ph d
Jane Hsiao, Ph.D. is the Vice Chairman & CTO at ASENSUS SURGICAL, INC. and OPKO HEALTH, INC. In these roles, she is responsible for the technical direction and innovation of the companies. Hsiao brings valuable expertise in research and development, contributing to advancements in medical technologies. Her commitment to innovation and improving patient care is essential in guiding ASENSUS and OPKO's projects. She collaborates with research teams to ensure the success of technological initiatives.
